Can Brain Stimulation Help Quiet the “Voices”?

A Clear Look at TMS & tDCS for Auditory Hallucinations


What Are TMS and tDCS?

Non-invasive ways to retune the brain

Transcranial Magnetic Stimulation (TMS)

  • Uses a magnetic coil placed on the scalp
  • Sends short magnetic pulses into targeted brain regions
  • Patients remain awake and return to normal activity afterward
  • FDA-approved for depression; off-label for hallucinations

Transcranial Direct Current Stimulation (tDCS)

  • Uses two electrodes to deliver a very low electrical current
  • Can “calm” overactive areas or stimulate underactive ones
  • Portable, discreet, and low-side-effect
  • Still experimental for psychosis

Why Brain Stimulation for Hallucinations?

Because certain brain areas fire when the voices do

  • Left temporal and temporo-parietal areas
  • Wernicke’s and right Wernicke’s areas
  • Fronto-temporal networks

What My Review of the Research Found


tDCS: Promising in Some Studies, Less Clear in Others

Study 1 – Twice-daily tDCS showed real benefits

  • 31% reduction in hallucinations
  • Only 8% improvement in the placebo group
  • Some patients maintained relief for three months
  • Suggests tDCS can meaningfully help when delivered more intensively

Study 2 – Once-daily tDCS did NOT outperform placebo

  • Active group improved 24%
  • Placebo improved 34%
  • Strong placebo effect overshadowed active results

TMS: Stronger and More Consistent Evidence

Study 3 – Low-frequency TMS to Wernicke’s areas

  • Significant improvement in hallucination severity
  • Better global clinical outcomes
  • Supported by MRI-guided targeting

Study 4 – Internal vs external voices

  • Both active and placebo TMS helped
  • External voices responded best
  • Highlights the importance of understanding hallucination type

Study 5 – High-frequency TMS: Short-term relief

  • Noticeable improvement at Day 14
  • Benefits faded by Day 21–30
  • Suggests frequency matters

The Placebo Effect: An Unexpected Clue

  • Structure, support, and therapeutic ritual matter
  • Expectation can influence perception
  • Psychosis may involve both neurobiology and cognition
  • A blended treatment model (brain + mind + environment) may hold the most promise

So… Are These Treatments Ready for Everyday Use?

  • TMS is FDA-approved for depression, but still off-label for hallucinations.
  • tDCS is experimental and primarily available in research settings.
  • Real potential for both TMS and tDCS
  • Stronger evidence for low-frequency TMS
  • A clear need for more studies on dose, frequency, and individualized targeting

What This Means for Care at Ania-ra Psychiatry

  • Exploring innovative treatments with a critical, patient-centered eye
  • Understanding psychosis through brain, body, and lived experience
  • Continuing to challenge outdated thinking about what is or isn’t possible in recovery
  • Help patients navigate the evidence
  • Discuss off-label options honestly
  • Collaborate with research centers when appropriate
  • Advocate for personalized, stigma-free care

Final Thoughts

Posted in

Ready to take the next step?

Get started with your healing journey

Other Posts

Discover more from Ania-Ra Psychiatry

Subscribe now to keep reading and get access to the full archive.

Continue reading